Palm Therapeutics, Inc.
PrivateLast Round
SAFE
Jan 25, 2024
Total Funding Raised
$1.44M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Palm Therapeutics, Inc. is a biotechnology company that provides research services and develops therapeutics to treat cancer using its proprietary small molecule drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palm Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Palm Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Jan 25, 2024 | ||||
| Grant | Aug 30, 2021 | ||||
| Grant | Nov 23, 2020 |
Key People
Founding team and executive leadership
Palm Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| SeedFolio | SAFE |
| National Institute of Neurological Disorders and Stroke | Grant |
| Tachyon Ventures | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 116% MoM, reaching 6.2K.
- Jan 20, 2026
Monthly visitors increased 41% MoM, from 681 to 957.
Palm Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Palm Therapeutics, Inc.'s valuation, stock price, and market status.